Farmacia Hospitalaria y Farmacogenómica

Arrabal-Duran, P; Duran-Garcia, ME; Ribed-Sanchez, A; Hidalgo-Collazos, P; Sanjurjo-Saez, M.

Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure

NEFROLOGIA. 2014; 34(6): 710-715 Nº de citas: 8 [doi:10.3265/Nefrologia.pre2014.Jul.12541]

de Lorenzo-Pinto, A; Sanchez-Galindo, AC; Manrique-Rodriguez, S; Fernandez-Llamazares, CM; Fernandez-Lafever, SN; San-Prudencio, MG; Cortejoso, L; Sanjurjo-Saez, M.

Prevention and treatment of intraluminal catheter thrombosis in children hospitalised in a paediatric intensive care unit

JOURNAL OF PAEDIATRICS AND CHILD HEALTH. 2014; 50(1): 40-46 Nº de citas: 6 [doi:10.1111/jpc.12404]

Vega, A; Abad, S; Verdalles, U; Aragoncillo, I; Velazquez, K; Quiroga, B; Escudero, V; Lopez-Gomez, JM.

Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease

Hippokratia. 2014; 18(4): 315-318 Nº de citas: 14

Sanchez, AR; Jimenez, RMR; de Orgaz, MCSG; Luna, MS; Saez, MS.

Aggressive parenteral nutrition and growth velocity in preterm infants

NUTRICION HOSPITALARIA. 2013; 28(6): 2128-2134 Nº de citas: 5 [doi:10.3305/nh.2013.28.6.6961]

Manrique-Rodriguez, S; Sanchez-Galindo, AC; Lopez-Herce, J; Calleja-Hernandez, MA; Martinez-Martinez, F; Iglesias-Peinado, I; Carrillo-Alvarez, A; Saez, MS; Fernandez-Llamazares, CM.

Impact of implementing smart infusion pumps in a pediatric intensive care unit

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2013; 70(21): 1897-1906 Nº de citas: 45 [doi:10.2146/ajhp120767]

Lasarte, S; Elsner, D; Sanchez-Elsner, T; Fernandez-Pineda, A; Lopez-Fernandez, LA; Corbi, AL; Munoz-Fernandez, MA; Relloso, M.

Estradiol downregulates NF-kappa b translocation by Ikbkg transcriptional repression in dendritic cells

GENES IMMUN. 2013; 14(7): 462-469 Nº de citas: 15 [doi:10.1038/gene.2013.35]

Moral, L; Torres-Borrego, J; Murua, JK; Valverde-Molina, J; Belinchon, JP; Praena-Crespo, M; Casanueva, CO; Callen-Blecua, MT; Fernandez-Llamazares, CM; Rey, CC.

Association between paracetamol exposure and asthma: update and practice guidelines

ANALES DE PEDIATRIA. 2013; 79(3): 188-188 Nº de citas: 2 [doi:10.1016/j.anpedi.2012.12.006]

Lopez, MCM; Romero, AJA; Lopez, ABM; Fernandez-Llamazares, CM; Navarro, CR.

Risk assessment of thrombotic events after the use of activated factor VII

ANALES DE PEDIATRIA. 2013; 79(3): 177-181 [doi:10.1016/j.anpedi.2012.11.006]

Jimenez, RMR; Lopez, MSP; Fresneda, MNS; Saez, MS.

VALIDATION OF ASEPTIC TECHNIQUE OF PARENTERAL NUTRITION COMPOUNDING IN A PHARMACY SERVICE ACCORDING TO USP CHAPTER 797

NUTRICION HOSPITALARIA. 2013; 28(5): 1494-1497

Fernandez-Llamazares, CM; Pozas, M; Feal, B; Cabanas, MJ; Villaronga, M; Hernandez-Gago, Y; de Villegas, MR; Alvarez-del-Vayo, C.

Profile of prescribing errors detected by clinical pharmacists in paediatric hospitals in Spain

International Journal of Clinical Pharmacy. 2013; 35(4): 638-646 Nº de citas: 23 [doi:10.1007/s11096-013-9785-9]

Ramirez-Herraiz, E; Escudero-Vilaplana, V; Alanon-Plaza, E; Trovato-Lopez, N; Herranz-Alonso, A; Morell-Baladron, A; Sanjurjo-Saez, M.

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013; 31(4): 559-565 Nº de citas: 28

Fernandez-Rozadilla, C; Cazier, JB; Moreno, V; Crous-Bou, M; Guino, E; Duran, G; Lamas, MJ; Lopez, R; Candamio, S; Gallardo, E; Pare, L; Baiget, M; Paez, D; Lopez-Fernandez, LA; Cortejoso, L; Garcia, MI; Bujanda, L; Gonzalez, D; Gonzalo, V; Rodrigo, L; Rene, JM; Jover, R; Brea-Fernandez, A; Andreu, M; Bessa, X; Llor, X; Xicola, R; Palles, C; Tomlinson, I; Castellvi-Bel, S; Castells, A; Ruiz-Ponte, C; Carracedo, A.

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration

PHARMACOGENOMICS JOURNAL. 2013; 13(3): 209-217 Nº de citas: 46 [doi:10.1038/tpj.2012.2]

Cortejoso, L; Garcia, MI; Garcia-Alfonso, P; Gonzalez-Haba, E; Escolar, F; Sanjurjo, M; Lopez-Fernandez, LA.

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2013; 71(6): 1463-1472 Nº de citas: 45 [doi:10.1007/s00280-013-2145-6]

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Bellon-Cano, JM; Sanjurjo-Saez, M.

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

International Journal of Clinical Pharmacy. 2013; 35(3): 463-468 Nº de citas: 5 [doi:10.1007/s11096-013-9774-z]

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Sanjurjo-Saez, M.

Equipotent Doses of Erythropoiesis-Stimulating Agents in Outpatients with Anaemia Secondary to Chronic Kidney Disease

LATIN AMERICAN JOURNAL OF PHARMACY. 2013; 32(3): 454-458

Romero Jimenez, RM; Calleja Hernandez, MA; Chaparro Recio, M; Martinez Martinez, F; Sanjurjo Saez, M.

Effect of Pharmacotherapy Follow-Up on Treatment Adherence and Virologic and Immune Response in Patients with Human Immunodeficiency Virus

LATIN AMERICAN JOURNAL OF PHARMACY. 2013; 32(3): 441-447 Nº de citas: 2

Rallon, NI; Lopez-Fernandez, LA; Garcia, MI; Benguria, A; Fiorante, S; Soriano, V; Benito, JM.

Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

AIDS. 2013; 27(5): 687-696 Nº de citas: 10 [doi:10.1097/QAD.0b013e32835ce2c1]

Yeste-Gomez, I; Rodriguez-Gonzalez, CG; Gimenez-Manzorro, A; Ais-Larisgoitia, A; Sanjurjo-Saez, M.

Information leaflets for patients with hepatitis C receiving treatment with triple therapy

EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2013; 20(1): 13-19 Nº de citas: 2 [doi:10.1136/ejhpharm-2012-000176]